Cargando…
An evaluation of a FluoroSpot assay as a diagnostic tool to determine SARS-CoV-2 specific T cell responses
Numerous assays evaluating serological and cellular responses have been developed to characterize immune responses against SARS-CoV-2. Serological assays are both cost- and time-effective compared to cellular assays, but cellular immune responses may provide a diagnostic value to determine previous...
Autores principales: | Mangsbo, Sara M., Havervall, Sebastian, Laurén, Ida, Lindsay, Robin, Jernbom Falk, August, Marking, Ulrika, Lord, Martin, Buggert, Marcus, Dönnes, Pierre, Christoffersson, Gustaf, Nilsson, Peter, Hober, Sophia, Phillipson, Mia, Klingström, Jonas, Thålin, Charlotte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483319/ https://www.ncbi.nlm.nih.gov/pubmed/34591918 http://dx.doi.org/10.1371/journal.pone.0258041 |
Ejemplares similares
-
Impact of SARS‐CoV‐2 infection on vaccine‐induced immune responses over time
por: Havervall, Sebastian, et al.
Publicado: (2022) -
Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines
por: Marking, Ulrika, et al.
Publicado: (2022) -
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID‐19
por: Havervall, Sebastian, et al.
Publicado: (2021) -
Immune responses after omicron infection in triple-vaccinated health-care workers with and without previous SARS-CoV-2 infection
por: Blom, Kim, et al.
Publicado: (2022) -
Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2
por: Havervall, Sebastian, et al.
Publicado: (2021)